Parvulet (TM) Technology- Patient Centric Dosing Solution

Product description

Adare has recently launched a new patient centric dosage solution, the Parvulet TM Technology. The Parvulet TM Technology enables a solid powder or tablet to convert to a semi-solid in the presence of water within thirty seconds. The final dosage is easily administered, as a soft food like texture, ideal for pediatric and geriatric populations (including those with dysphagia).

Read more

Specifications

Categories Pharmaceutical Machinery & TechnologyControlled, customized or modified drug release; Contract Services - Contract ServicesFormulation development
Sales markets Eastern Europe; North America; Central/South America
Supplied from United States

More products from Adare Pharmaceuticals, Inc.

Products from other suppliers

Parvulet (TM) Technology- Patient Centric Dosing Solution

Contact information

Address

Telephone

Website

View all contact information